To make further progress in understanding the unique cardiac disease characteristics of patients with HFpEF and a normal NT-proBNP level and to better tailor treatment, future studies should ...

For patients with chronic unexplained dyspnea seen in the outpatient setting, the optimal thresholds of plasma NT-proBNP currently used to diagnosis heart failure with preserved ejection fraction ...

Please provide your email address to receive an email when new articles are posted on . Empagliflozin was safe and effective in patients with HF with reduced ejection fraction regardless of systolic ...

Wanting more data on the benefits of sacubitril/valsartan vs renin angiotensin system inhibitor background therapy, investigators conducted a large randomized study among persons with heart failure ...

A simple blood test for the protein NT-proBNP accurately predicts the risk of heart attack, heart failure, stroke, and death in patients with known cardiovascular disease, according to a study led by ...

"HF algorithms are starting to recognize and include NT-proBNP in identifying stage B HF…Studies such as ours could provide insight and guidance as to when repeat measures may be useful. Future work ...

Please provide your email address to receive an email when new articles are posted on . Select adults with ischemic heart failure with reduced ejection fraction may derive benefit from an ...

The phase 2 trial showed that coramitug, an antibody targeting misfolded transthyretin in ATTR-CM, was well tolerated. A dose of 60 mg/kg resulted in a statistically significant reduction in NT-proBNP ...